Food Choices in Type I Diabetes
Evaluate food choices in patients with Type 1 diabetes.
Evaluate food choices in patients with Type 1 diabetes.
Determine how potentially stressful situations, including prematurity, hospitalizations, maternal mental health and rapid repeat births can impact a baby’s development in the first 12 months of their life.
To investigate the connection between diet, genetics, and diseases in Hispanic / Latino youth.
1) To determine if 5 doses of Epo (Erythropoietin) 1000 U/kg (birth weight) intravenous (IV) reduces the rate of death or neurodevelopmental impairment (mild, moderate, or severe) at 24 months of age.
2) To assess safety of Epo.
3) To determine whether Epo decreases the severity of HIE-induced brain injury as evidenced by early MRI and plasma biomarkers of brain injury.
To evaluate how the Medtronic 670G closed loop system impacts clinical and patient-reported outcomes in individuals with type 1 diabetes.
Hydroxychloroquine is given as an investigational drug to relatives of someone with type 1 diabetes who have positive diabetes antibodies in an attempt to prevent or delay the onset of type 1 diabetes. See website for more details https://www.trialnet.org/our-research/prevention-studies/hydroxychloroquine-hcq
We are interested in observing whether and how infants learn when interacting with a robot during a learning assessment contingency paradigm.
The effect of flu immunization on the level of immunity against the flu in breastmilk, and how this may help protect a breastfeeding infant.
Our goal is early identification of deviation from healthy brain development to allow targeted early intervention and improve developmental outcomes.
To determine if a home visitation program for breastfeeding mothers affects the health of their babies.